Defence And Security Tenders

Conclusion of a Non-Exclusive Framework Agreement for Planning Services for Landscape Conservation Accompanying Planning in Accordance with Hoai, Environmental Contributions and Special Services in the Open House Procedure

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Conclusion of an Open House Framework Agreement "Direct Personnel Placement"

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Aok - Priomed Secondary Prevention According to § 140A Sgb V

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Fulvestrant (Atc Code According to Who: L02ba03)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Certolizumab Pegol (Atc Code According to Who: L04ab05)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Infliximab (Atc Code According to Who: L04ab02)

Building Cleaning - Maintenance and Basic Cleaning

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Iron (Ii) Sulfate (B03aa07) as Part of a So-Called Open House Model.